Skip to main content
. 2022 May 16;16:1457–1471. doi: 10.2147/DDDT.S356988

Table 3.

Inhibitory Activity of 7b, 7g, 7l and 7m Against EGFR

Compound IC50 (nM)
EGFR
7b 83±4
7g 262±13
7l 171±9
7m 305±16
Erlotinib 57±3